1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
CAS: 3374-05-8
Ref. IN-DA00I6N3
| 1g | Descontinuado | ||
| 5g | Descontinuado | ||
| 25g | Descontinuado | ||
| 100mg | Descontinuado |
Informação sobre produto
Nome:
1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
Sinónimos:
- [u'Acid, Nalidixic', u'Anhydrous, Nalidixate Sodium', u'Nalidixate Sodium', u'Nalidixate Sodium Anhydrous', u'Nalidixic Acid', u'Nalidixin', u'Nevigramon', u'Sodium Anhydrous, Nalidixate', u'Sodium Nalidixic Acid, Anhydrous', u'Sodium Nalidixic Acid, Monohydrate', u'Sodium, Nalidixate', u'Nalidixic acid sodium salt', u'Baktogram', u'Nalidixic acid sodium', u'3374-05-8', u'Sodium nalidixate', u'Chemiurin', u'Dixilina', u'NALIDIXATE SODIUM', u'UNII-Y7NU182221', u'Nalidixate sodium anhydrous [USAN]', u'EINECS 222-159-7', u'MFCD00064376', u'Y7NU182221', u'Win 18320', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid sodium salt', u'Nalidixate sodium anhydrous', u'Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'CPD000326712', u'SMR000326712', u'AC1MYZ5W', u'Lopac-N-4382', u'MLS001056754', u'MLS002548848', u'Nalidixate Sodium (anhydrous)', u'SCHEMBL9743577', u'CHEMBL1255939', u'CTK8B3279', u'Sodium Nalidixic Acid, Anhydrous', u'BIN4302', u'ZX-AFC000602', u'HMS3262H15', u'HMS3714G09', u'Tox21_500837', u'ANW-42193', u'GA0875', u'AKOS024307522', u'AKOS026749975', u'API0003487', u'CCG-220674', u'CCG-222141', u'LP00837', u'WIN-183203', u'NCGC00016177-01', u'NCGC00016177-02', u'NCGC00016177-03', u'NCGC00094168-01', u'NCGC00261522-01', u'BP-12504', u'LS-95957', u'SAM002264626', u'SAM002699905', u'EU-0100837', u'FT-0634810', u'K-0042', u'N 4382', u'C-25525', u'J-009440', u'J-019311', u'sodium 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'potassium 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'sodium 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid sodium', u'1-OO>>u-1,4- paragraph signthornCa-7-(1/4)x>>u-4-No u-1,8-YAa currency-3-oEEa AAENI', u'nalidixic acid', u'C12H11N2O3.Na', u'Nalidixic acid sodium salt hydrate', u'CID27477', u'CID3864541', u'NALIDIXIC ACID, SODIUM SALT HYDRATE', u'Nalidixic acid sodium salt, 98% - 1G 1g', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid', u'15769-77-4']
- 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
- 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt (1:1)
- Nalidixate sodium
- Nalidixic Acid Sodium
- Nalidixic Acid Sodium Gamma-Irradiated*Molecular
- Sodium 1-Ethyl-7-Methyl-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxylate
- Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
- Sodium nalidixate
- Win 18320-3
- Ver mais sinónimos
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
254.2171
Fórmula:
C12H11N2NaO3
Pureza:
98%
Cor/forma:
Solid
InChI:
InChI=1S/C12H12N2O3.Na/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14;/h4-6H,3H2,1-2H3,(H,16,17);/q;+1/p-1
Chave InChI:
ROKRAUFZFDQWLE-UHFFFAOYSA-M
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
